Basal Insulin-Fc (BIF) is currently in clinical development for adults with type 1 diabetes (T1D). T1D is a chronic condition where the pancreas makes little or no insulin. Insulin is a hormone the body uses to allow sugar (glucose) to enter cells to produce energy. Symptoms of T1D include thirst, weight loss and frequent need to use the toilet. There are currently no cures for T1D, and the treatment options are limited to daily insulin injections which can hinder adherence to treatment and be a burden to individuals.
Basal Insulin-Fc for treating type 1 diabetes
Basal Insulin-Fc (BIF) is currently in clinical development for adults with type 1 diabetes (T1D). T1D is a chronic condition where the pancreas makes little or no insulin.
Interventions:
Basal Insulin-Fc
Indications:
Type 1 diabetes
Therapeutic Areas:
Endocrine Nutritional and Metabolic Disorders
Year:
2023